
FDA approves gardenia blue as natural color additive for food use
The FDA approves gardenia (genipin) blue as a natural food color, enhancing options for manufacturers and supporting the shift away from synthetic dyes.
The US Food and Drug Administration (FDA) has approved the use of gardenia (genipin) blue as a color additive in food, marking the fourth natural-source color approved in recent months.1,2
The July 14, 2025, decision authorizes the colorant’s use in sports drinks, flavored or enhanced non-carbonated water, fruit drinks and ades, ready-to-drink teas, hard candy, and soft candy, when used at levels consistent with good manufacturing practice.
Gardenia blue is derived from the fruit of the gardenia, a flowering evergreen. The FDA’s approval followed a petition by the Gardenia Blue Interest Group (GBIG) and was granted under section 721 of the Federal Food, Drug, and Cosmetic Act. The law requires that all color additives be reviewed and approved by the FDA before being used in foods. Evaluation criteria include projected human dietary exposure, toxicological data, and relevant literature to ensure a “reasonable certainty of no harm.”
“This expedited timeline underscored our serious intent to transition away from petroleum-based synthetic dyes in the food supply,” said FDA Commissioner Marty Makary, MD, MPH. “Now, by expanding the palette of available colors derived from natural sources, food manufacturers have a variety of options available that will make it easier to end their use of petroleum-based dyes.”
The approval of gardenia blue follows the agency’s May 2025 authorization of 3 other naturally derived food colors: galdieria extract blue, a pigment from the red algae Galdieria sulphuraria; calcium phosphate, a white powder; and butterfly pea flower extract, which can produce bright blue, purple, and green hues.
These approvals support a broader initiative by the US Department of Health and Human Services (HHS) to reduce the presence of synthetic, petroleum-based color additives in the US food supply.
According to HHS, approximately 40% of the food industry has voluntarily committed to removing synthetic dyes since the initiative was launched.
As part of these ongoing efforts, the FDA also encouraged food manufacturers to accelerate the removal of FD&C Red No. 3 from products ahead of its January 15, 2027, phase-out deadline.
To support early compliance, the FDA issued a letter urging manufacturers to begin reformulating products as soon as practicable. “The FDA believes that accelerating the phase out of the use of FD&C Red No. 3 in foods will help further the goal of Making America Healthy Again,” the agency stated.
The FDA acknowledged the challenges involved in replacing synthetic dyes and noted that substitutions may require the expanded use of approved color additives or the development of new ones. Regardless of source, all additives must meet the FDA’s safety standards.
On July 11, 2025, Consumer Brands, a national trade association, announced a voluntary pledge to remove all certified FD&C colors from foods served in schools by the 2026–2027 academic year.
The continued expansion of natural color options, including the recent approval of gardenia blue, offers food manufacturers more tools to comply with evolving regulatory expectations and public health priorities.
References:
- FDA. FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3. U.S. Food and Drug Administration. July 14, 2025. Accessed July 14, 2025. https://www.fda.gov/news-events/press-announcements/fda-approves-gardenia-genipin-blue-color-additive-while-encouraging-faster-phase-out-fdc-red-no-3?utm_medium=email&utm_source=govdelivery
- FDA. FDA Encourages Food Manufacturers to Accelerate Phasing Out the Use of FD&C Red No. 3 in Foods Before 2027 Deadline. July 14, 2025. Accessed July 14, 2025. Press release.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

![Jodi Gilman, PhD, on cumulative prenatal adversity linked to adolescent mental health risk Document Jodi Gilman, PhD, on cumulative prenatal adversity linked to adolescent mental health risk Live? Do you want this document to be visible online? Scheduled Publishing Exclude From Home Page Do you want this document to be excluded from home page? Exclude From Infinite Scroll Do you want this document to be excluded from infinite scroll? Disable Related Content Remove related content from bottom of article. Password Protection? Do you want this gate this document? (If so, switch this on, set 'Live?' status on and specify password below.) Hide Comments [Experiment] Comments are visible by default. To hide them for this article toggle this switch to the on position. Show Social Share Buttons? Do you want this document to have the social share icons? Healthcare Professional Check Is Gated [DEV Only]Do you want to require login to view this? Password Password required to pass the gating above. Title Jodi Gilman, PhD, on cumulative prenatal adversity linked to adolescent mental health risk URL Unique identifier for this document. (Do not change after publishing) jodi-gilman-phd-on-cumulative-prenatal-adversity-linked-to-adolescent-mental-health-risk Canonical URL Canonical URL for this document. Publish Date Documents are usually sorted DESC using this field. NOTE: latency may cause article to publish a few minutes ahead of prepared time 2026-01-19 11:52 Updated On Add an updated date if the article has been updated after the initial publish date. e.g. 2026-01-19 11:50 Article Type News Display Label Author Jodi Gilman, Phd > Gilman, Jodi Author Fact Check Assign authors who fact checked the article. Morgan Ebert, Managing Editor > Ebert, Morgan Content Category Articles Content Placement News > Mental, Behavioral and Development Health > Clinical AD Targeting Group Put the value only when the document group is sold and require targeting enforcement. Type to search Document Group Mapping Now you can assign multiple document group to an article. No items Content Group Assign a content group to this document for ad targeting. Type to search Issue Association Please choose an issue to associate this document Type to search Issue Section Please choose a section/department head if it exists Type to search Filter Please choose a filter if required Type to search Page Number Keywords (SEO) Enter tag and press ENTER… Display summary on top of article? Do you want display summary on top of article? Summary Description for Google and other search engines; AI generated summary currently not supporting videos. Cumulative prenatal adversities were linked to higher adolescent mental health risk, highlighting the importance of prenatal history and early clinical monitoring. Abstract Body *********************************************************************************************************** Please include at least one image/figure in the article body for SEO and compliance purposes ***********************************************************************************************************](https://cdn.sanity.io/images/0vv8moc6/contpeds/e6097cb5e6d6c028c0d4e9efd069e69fdab6d00b-1200x628.png?w=350&fit=crop&auto=format)






